COVID-19: -

Our Commitment to Client Service & Investor Communications

Dr Dorothea Hill

Life Sciences Analyst

Dr Dorothea Hill joined the Life Sciences team as an Equity Research Analyst in August 2016.

She began her career researching vaccines as part of an international Gates Foundation/Wellcome Trust collaboration, following which she undertook a PhD in genetics and vaccines for meningococcal disease at the University of Oxford. She has broad experience in the field of vaccines research and development, having worked on the molecular biology of bacterial pathogens, antigen discovery, molecular diagnostics, and next-generation sequencing technologies. Dorothea has authored 13 papers, including first author publications in the Lancet Infectious Diseases and in Nature’s Scientific Reports.

She is passionate about drug development and the commercialisation of medical innovation.